<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 04 Apr 2026 20:24:42 -0400--><rss version="2.0">
    <channel>
        <title>Veru Inc. (VERU) SEC Filings</title>
        <link>https://ir.verupharma.com/sec-filings/quarterly-reports/rss</link>
        <description>Veru Inc. (VERU) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/verupharma/files/theme/images/logo-sm.png</url>
                <title>Veru Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-003725/0001437749-26-003725.pdf</link>
                <pubDate>Wed, 11 Feb 26 10:32:52 -0500</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-003725/0001437749-26-003725.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-026072/0001437749-25-026072.pdf</link>
                <pubDate>Tue, 12 Aug 25 10:45:02 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-026072/0001437749-25-026072.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[6 Related Documents: 10-Q, EX-10.1, EX-10.2, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-015330/0001437749-25-015330.pdf</link>
                <pubDate>Thu, 08 May 25 11:51:54 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-015330/0001437749-25-015330.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-003734/0001437749-25-003734.pdf</link>
                <pubDate>Thu, 13 Feb 25 14:36:02 -0500</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-003734/0001437749-25-003734.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-24-025338/0001437749-24-025338.pdf</link>
                <pubDate>Thu, 08 Aug 24 10:46:37 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-24-025338/0001437749-24-025338.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-24-000011/0000863894-24-000011.pdf</link>
                <pubDate>Wed, 08 May 24 13:10:42 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-24-000011/0000863894-24-000011.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-24-000008/0000863894-24-000008.pdf</link>
                <pubDate>Mon, 01 Apr 24 15:43:40 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-24-000008/0000863894-24-000008.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]></title>
                <description><![CDATA[NT 10-Q]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-24-037621/0001193125-24-037621.pdf</link>
                <pubDate>Thu, 15 Feb 24 16:50:27 -0500</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-24-037621/0001193125-24-037621.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q/A - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-Q/A, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-23-000012/0000863894-23-000012.pdf</link>
                <pubDate>Wed, 15 Nov 23 16:55:39 -0500</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-23-000012/0000863894-23-000012.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-23-000009/0000863894-23-000009.pdf</link>
                <pubDate>Thu, 10 Aug 23 12:54:48 -0400</pubDate>
                <guid>https://ir.verupharma.com/sec-filings/all-sec-filings/content/0000863894-23-000009/0000863894-23-000009.pdf</guid>
                                                                            </item>
            </channel>
</rss>